Recent Chemotherapy May Increase COVID-19 Mortality Risk for Patients With Thoracic Cancer
May 29th 2020Chemotherapy administered within 3 months of a diagnosis of coronavirus disease 2019 (COVID-19) increased the risk of death in patients with thoracic cancer, according to findings from the global TERAVOLT Consortium registry.